$1.170
-0.029 (-2.50%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Brainstorm Cell Therapeutics Inc (BCLI) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting BCLI is Sell.
Brainstorm Cell Therapeutics Inc (BCLI) 20-Day simple moving average is 1.18, while Brainstorm Cell Therapeutics Inc (BCLI) share price is $—, making it Sell.
Brainstorm Cell Therapeutics Inc (BCLI) 60-Day simple moving average is 1.16, while Brainstorm Cell Therapeutics Inc (BCLI) share price is $—, making it Buy.
Technical Analysis for BCLI
AI Technical BCLIAs of 2025-07-17, the technical board for Brainstorm Cell Therapeutics Inc (BCLI) reads sell: 3 indicators are flashing buy, 5 are indicating sell, and 4 are neutral. Price at $1.17 sits below the 5-day, 10-day, 20-day and 200-day moving averages and above the 60-day.
Momentum readings: RSI stands at 48.724, MACD stands at 0.00828 (Buy), Stochastic %K stands at 56.667, Stochastic %D stands at 58.889 and CCI stands at -32.421.
BCLI trades above the 60-day SMA (1.16) and below the 200-day SMA (1.57). Immediate resistance sits at Classic R1 1.34, then R2 1.47. Support sits at Classic S1 1.05, then S2 0.89.
Brainstorm Cell Therapeutics Inc (BCLI) Support & Resistance Level
Brainstorm Cell Therapeutics Inc (BCLI) Technical Indicators
2025-07-17
| Name | Value |
|---|---|
| RSI_14 | 48.724 |
| STOCHk_14_3_3 | 56.667 |
| STOCHd_14_3_3 | 58.889 |
| CCI_20 | -32.421 |
| AO_5_34 | 0.017 |
| MACD_12_26_9 | 0.008 |
Brainstorm Cell Therapeutics Inc (BCLI) Relative Strength Index (RSI_14) is 48.724, creating a Neutral signal.
Brainstorm Cell Therapeutics Inc (BCLI) Stochastic %K is 56.667, creating a Neutral signal.
Brainstorm Cell Therapeutics Inc (BCLI) Stochastic %D is 58.889, creating a Neutral signal.
Brainstorm Cell Therapeutics Inc (BCLI) CCI_20 is -32.421, creating a Neutral signal.
Brainstorm Cell Therapeutics Inc (BCLI) Awesome Oscillator (AO) is 0.017, creating a Buy signal.
Brainstorm Cell Therapeutics Inc (BCLI) Moving Average Convergence Divergence (MACD) is 0.008, creating a Buy signal.
Brainstorm Cell Therapeutics Inc (BCLI) Moving Average
2025-07-17
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 1.194 | Sell |
| MA_10 | 1.204 | Sell |
| MA_20 | 1.181 | Sell |
| MA_60 | 1.163 | Buy |
| MA_200 | 1.574 | Sell |
| MA_250 | 2.170 | Sell |
Brainstorm Cell Therapeutics Inc (BCLI) 5-Day simple moving average is 1.194, while Brainstorm Cell Therapeutics Inc (BCLI) share price is $, making it a Sell.
Brainstorm Cell Therapeutics Inc (BCLI) 10-Day simple moving average is 1.204, while Brainstorm Cell Therapeutics Inc (BCLI) share price is $, making it a Sell.
Brainstorm Cell Therapeutics Inc (BCLI) 20-Day simple moving average is 1.181, while Brainstorm Cell Therapeutics Inc (BCLI) share price is $, making it a Sell.
Brainstorm Cell Therapeutics Inc (BCLI) 60-Day simple moving average is 1.163, while Brainstorm Cell Therapeutics Inc (BCLI) share price is $, making it a Buy.
Brainstorm Cell Therapeutics Inc (BCLI) 200-Day simple moving average is 1.574, while Brainstorm Cell Therapeutics Inc (BCLI) share price is $, making it a Sell.
Brainstorm Cell Therapeutics Inc (BCLI) 250-Day simple moving average is 2.170, while Brainstorm Cell Therapeutics Inc (BCLI) share price is $, making it a Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.